CalciMedica Q2 EPS $(1.11) Down From $(0.38) YoY
Portfolio Pulse from Benzinga Newsdesk
CalciMedica (NASDAQ:CALC) reported Q2 losses of $(1.11) per share, a 192.11% increase from $(0.38) per share losses in the same period last year.
August 10, 2023 | 9:12 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
CalciMedica's Q2 losses per share have significantly increased compared to the same period last year.
The significant increase in losses per share indicates a worsening financial situation for CalciMedica, which could negatively impact investor sentiment and drive the stock price down in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100